Aims

  1. Replace bone marrow aspirates with minimal invasive personalized proteogenomics for better quality of life and to improve MRD monitoring and risk-stratification.
  2. Strengthen our collaborative network of key stakeholders to realize a structural pipeline of biomarker development towards implementation of novel diagnostic workflows.
  3. Welcome new collaborations to synergize on our experience with single-cell analysis of immune cells in cancer patients. Through more intense crossing borders collaborations, we want to valorize this facility by addressing key agenda topics in the onco-immunology field such as: ‘Immune fitness in cancer patients’, ‘Immune tracking during cancer immunotherapy’, ‘Identification of early prognostic cancer biomarkers’, and ‘Evidence-based drug dose reduction’.


go to main content
Research Research groups Personalized onco-immunology diagnostics

About

We aim to understand the complex interplay between cancer and the immune system and to develop novel cancer-diagnostics that have a significant impact for patients.

Research group leader

dr. Hans Jacobs

contact form

Aims

See our most important goals.

read more

Publications

See some of our most important scientific articles.

read more

Publications


Internationally we are also known as

Jacobs-lab